Matching cancer genes and immune cells key to unlocking immune system’s treatment power

In a strategy that combines two of the hottest ideas in cancer research, scientists at the National Institutes of Health said they developed a method that successfully attacked tumors by using the body’s immune system to home in on genetic mutations unique to a patient’s cancer.

The findings, published Thursday in the journal Science, are from the study of a single patient—a 45-year-old woman from Montana. But researchers said her case, in which she received billions of immune cells specially grown to target her tumor, amounts to evidence the technique could potentially be a way to treat many common cancers now considered difficult to target with the immune system.

So-called immunotherapy, which seeks to harness the immune system to attack cancer cells, has so far shown the most promise in relatively rare tumors like melanoma and kidney cancers.

Related on the SLP

No related posts.

Viewpoint: The shocking consequences after a year of Robert F. Kennedy Jr.’s distortions, deceptions, and flat-out falsehoods

Retreat from identity labels: Does the sharply declining number of young teens identifying as gay and bisexual reflect an ideological shift?

MAHA moms divided over RFK Jr.’s food‑safety efforts, as recall alerts grow and outbreaks spread

Read the full, original story: Patient’s Immune System Harnessed to Attack Cancer